We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Key insights of simulation workshops from the AI Airlock testing programme. You should note that these documents are not formal guidance.
The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions early access to medicines that show early signs of having a major advantage over existing therapeut…
What you need to do to supply authorised medicines from Great Britain to Northern Ireland.
A poster explaining the different symbols used on medical devices.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing, access and growth in 2026.
Guidance on how to report suspected adverse incidents and safety concerns with diabetes management equipment to the Yellow Card scheme.
How to best protect patients and volunteers during magnetic resonance imaging (MRI) examinations.
This report reviews data on patient doses and equipment trends in dental X-ray imaging procedures between 2014 and 2017.
How to make sure that you are providing the statistical data required as part of a clinical investigation of your medical device.
How to make sure your clinical investigation will meet the MHRA's requirements for medical devices.
Links to EU guidance, as it stood immediately before end of transition period.
This publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products.
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
This publication supports local authority health and wellbeing boards to develop and update pharmaceutical needs assessments (PNAs).
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
How manufacturers can comply with the regulations when providing instructions for using medical devices in an electronic form.
How to carry out the biological safety evaluation, which is required before undertaking a clinical investigation for a medical device.
MHRA’s mechanism for evaluating the justifications supplied by applicant organisations who plan to utilise decentralised manufacture.
How investigators and sponsors should manage clinical trials during COVID-19
Clinical trials Route B substantial modifications pilot starts on 1 October 2025. Prepare for the implementation of new regulations from 28 April 2026.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).